EDNSF logo

Eden Research plc (EDNSF) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

EDNSF, $ (piyasa değeri 0) fiyatla Basic Materials işi olan Eden Research plc'i temsil ediyor. Hisse senedi, 9 kantitatif KPI'ya dayalı olarak orta dereceli bir derecelendirme olan 54/100 puan alıyor.

Son analiz: 17 Mar 2026
54/100 AI Puanı

Eden Research plc (EDNSF) Malzemeler ve Emtia Maruziyeti

CEOSean Michael Smith
Çalışanlar23
MerkezAbingdon, GB
Halka Arz Yılı2021

Eden Research plc provides sustainable crop protection, animal health, and consumer products, primarily in the UK and Europe. With a focus on bio-based solutions, the company addresses foliar diseases, insect control, and post-harvest preservation, operating in the agricultural inputs sector.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 17 Mar 2026

Yatırım Tezi

Eden Research plc presents a compelling investment case based on the increasing demand for sustainable agricultural solutions. The company's focus on bio-based crop protection and animal health products aligns with the growing trend towards environmentally friendly practices. Key value drivers include the expansion of its product portfolio and penetration into new geographic markets. The company's negative P/E ratio of -7.49 and negative profit margin of -65.0% indicate it is not yet profitable, representing a risk. A key catalyst is the potential for increased adoption of its products due to stricter regulations on traditional chemical pesticides. The company's relatively small market capitalization of $0.02 billion suggests significant growth potential if it can successfully execute its expansion strategy.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Market capitalization of $0.02 billion indicates a small-cap company with potential for high growth.
  • Negative P/E ratio of -7.49 reflects current unprofitability but potential for future earnings growth.
  • Gross margin of 38.5% demonstrates the company's ability to generate revenue above the cost of goods sold.
  • Beta of 1.67 suggests higher volatility compared to the market, indicating potential for larger price swings.
  • Focus on sustainable solutions aligns with increasing environmental awareness and regulatory pressures.

Rakipler & Benzerleri

Güçlü Yönler

  • Sustainable and environmentally friendly products.
  • Proprietary microencapsulation technology.
  • Diversified product portfolio.
  • Established presence in the UK and Europe.

Zayıflıklar

  • Small market capitalization.
  • Negative profitability.
  • Limited geographic reach.
  • Reliance on regulatory approvals.

Katalizörler

  • Upcoming: Potential regulatory approvals for new bio-based products.
  • Ongoing: Increasing demand for sustainable agricultural solutions.
  • Ongoing: Expansion into new geographic markets.
  • Ongoing: Development of new product formulations.
  • Ongoing: Strategic partnerships and acquisitions.

Riskler

  • Potential: Competition from larger agricultural companies.
  • Potential: Changes in environmental regulations.
  • Potential: Economic downturns affecting agricultural spending.
  • Potential: Fluctuations in raw material prices.
  • Ongoing: Limited financial disclosure due to OTC listing.

Büyüme Fırsatları

  • Expansion into New Geographic Markets: Eden Research has the opportunity to expand its presence beyond the UK and Europe. The global market for biopesticides is growing, particularly in regions with stringent environmental regulations. Entering new markets could significantly increase revenue and market share. Timeline: Ongoing.
  • Development of New Products: Investing in research and development to create new bio-based solutions for crop protection, animal health, and consumer products. This could involve developing products that target specific pests or diseases, or creating formulations that are more effective and environmentally friendly. Timeline: Ongoing.
  • Strategic Partnerships and Acquisitions: Partnering with or acquiring other companies in the agricultural inputs or biotechnology sectors. This could provide access to new technologies, markets, or distribution channels. Strategic alliances could accelerate growth and enhance the company's competitive position. Timeline: Ongoing.
  • Increased Adoption of Sustainable Farming Practices: The growing trend towards sustainable farming practices is creating a greater demand for bio-based crop protection products. Eden Research can capitalize on this trend by promoting the benefits of its products and educating farmers about sustainable agriculture. Timeline: Ongoing.
  • Regulatory tailwinds: Stricter regulations on chemical pesticides are driving demand for bio-based alternatives. Eden Research can benefit from these regulatory changes by offering products that meet the new standards and providing solutions for farmers who need to comply with stricter regulations. Timeline: Ongoing.

Fırsatlar

  • Expansion into new geographic markets.
  • Development of new bio-based products.
  • Strategic partnerships and acquisitions.
  • Increased adoption of sustainable farming practices.

Tehditler

  • Competition from larger agricultural companies.
  • Changes in environmental regulations.
  • Economic downturns affecting agricultural spending.
  • Fluctuations in raw material prices.

Rekabet Avantajları

  • Proprietary microencapsulation technology enhances product efficacy and delivery.
  • Focus on sustainable solutions aligns with increasing environmental regulations.
  • Established presence in the UK and European markets.
  • Diversified product portfolio across crop protection, animal health, and consumer products.

EDNSF Hakkında

Eden Research plc, founded in 1995 and headquartered in Abingdon, UK, develops and supplies sustainable solutions for crop protection, animal health, and consumer products. The company's core business revolves around providing environmentally friendly alternatives to traditional chemical products. Their crop protection line addresses critical agricultural needs, including foliar disease and insect control in open fields and greenhouses, soil pest management, post-harvest shelf-life extension, and seed treatment applications. These products aim to reduce the environmental impact of farming while maintaining crop yields and quality. In the animal health sector, Eden Research offers solutions for companion animals, bio-control agents, parasite treatments, and insect spray products. These products focus on providing effective and safe treatments for pets and livestock. Additionally, the company caters to the human health market with products like head-lice treatments, fragrances, deodorants, wound-care solutions, food flavorings, odor neutralizers, and active ingredient supply/delivery systems. Eden Research's geographic focus is primarily the United Kingdom and the rest of Europe, where it aims to capitalize on the growing demand for sustainable and environmentally responsible products. The company's competitive advantage lies in its focus on bio-based solutions and its ability to develop products that meet stringent regulatory requirements.

Ne Yaparlar

  • Develops and supplies sustainable crop protection products.
  • Offers solutions for foliar disease and insect control.
  • Provides products for open field and greenhouse applications.
  • Creates solutions for soil pests and post-harvest shelf-life extension.
  • Offers seed treatment applications.
  • Develops animal health products, including bio-control and parasite treatments.
  • Provides human health products, such as head-lice treatments and fragrances.
  • Supplies active ingredient delivery products.

İş Modeli

  • Develops and manufactures bio-based crop protection, animal health, and consumer products.
  • Sells products directly to farmers, distributors, and retailers.
  • Generates revenue through product sales and licensing agreements.
  • Focuses on sustainable and environmentally friendly solutions.

Sektör Bağlamı

Eden Research plc operates within the agricultural inputs industry, which is experiencing a shift towards sustainable and environmentally friendly solutions. The global market for biopesticides is projected to grow significantly, driven by stricter regulations on chemical pesticides and increasing consumer demand for organic products. Competitors include companies like BNNHF (BioNano Health Foods Inc.), GLDRF (Golden Ridge Resources Inc.), HMIFF (HempMyLife Inc.), KMMIF (Kainantu Mining Corp), and KNGW (Kingwest Resources Ltd). Eden Research differentiates itself through its focus on microencapsulation technology and its portfolio of bio-based products.

Kilit Müşteriler

  • Farmers seeking sustainable crop protection solutions.
  • Distributors and retailers of agricultural products.
  • Consumers looking for environmentally friendly animal health and human health products.
AI Güveni: 69% Güncellendi: 17 Mar 2026

Finansallar

Grafik & Bilgi

Eden Research plc (EDNSF) hisse senedi fiyatı: Price data unavailable

Son Haberler

EDNSF için son haber bulunmamaktadır.

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

EDNSF için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

EDNSF için Wall Street fiyat hedefi analizi.

MoonshotScore

54/100

Bu puan ne anlama geliyor?

MoonshotScore, EDNSF'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Yönetim: Sean Michael Smith

CEO

Sean Michael Smith serves as the CEO of Eden Research plc, leading a team of 23 employees. Information regarding his detailed career history, education, and previous roles is not available in the provided data. Therefore, a comprehensive background profile cannot be generated at this time.

Sicil: Due to the limited information available, a detailed track record of Sean Michael Smith's achievements, strategic decisions, and company milestones under his leadership cannot be provided. Further research would be needed to assess his impact on Eden Research plc.

EDNSF OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the OTC market, indicating that Eden Research plc may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: Liquidity for EDNSF on the OTC market is likely limited, given its listing on the OTC Other tier. This can result in wider bid-ask spreads and difficulty in executing large trades without significantly impacting the price. Investors should exercise caution and be aware of the potential for price volatility due to low trading volumes.
OTC Risk Faktörleri:
  • Limited financial disclosure increases information asymmetry.
  • Lower liquidity can lead to price volatility and difficulty in exiting positions.
  • Potential for fraud or mismanagement due to reduced regulatory oversight.
  • Higher risk of delisting or trading suspensions.
  • OTC Other tier stocks may not be marginable.
Durum Tespiti Kontrol Listesi:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the background and experience of the company's management team.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's capital structure and debt levels.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before investing.
  • Check for any regulatory actions or legal proceedings against the company.
Meşruiyet Sinyalleri:
  • Company has been in operation since 1995.
  • Focus on sustainable solutions aligns with current market trends.
  • Presence in the UK and European markets.
  • Development of proprietary microencapsulation technology.
  • Offers a diversified product portfolio.

EDNSF Hakkında Sıkça Sorulan Sorular

EDNSF için değerlendirilmesi gereken temel faktörler nelerdir?

Eden Research plc (EDNSF) şu anda yapay zeka skoru 54/100, orta puanı gösteriyor. Temel güçlü yan: Sustainable and environmentally friendly products.. İzlenmesi gereken birincil risk: Potential: Competition from larger agricultural companies.. Bu bir finansal tavsiye değildir.

EDNSF MoonshotScore'u nedir?

EDNSF şu anda MoonshotScore'da 54/100 (Derece C) alıyor, bu da orta derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

EDNSF verileri ne sıklıkla güncellenir?

EDNSF fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler EDNSF hakkında ne diyor?

EDNSF için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

EDNSF'a yatırım yapmanın riskleri nelerdir?

EDNSF için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Competition from larger agricultural companies.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

EDNSF'ın P/E oranı nedir?

EDNSF için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için EDNSF'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

EDNSF aşırı değerli mi, yoksa düşük değerli mi?

Eden Research plc (EDNSF)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

EDNSF'ın temettü verimi nedir?

Eden Research plc (EDNSF) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Limited information available on CEO's background and track record.
  • OTC market investments carry higher risks than exchange-listed stocks.
  • Financial data is based on the most recent available information.
Veri Kaynakları

Popüler Hisseler